These discrepancies in study results may be related to several factors, such as the etiologies of hypopituitarism that are related to decreased IS regardless of decreased GH levels, as in patients with craniopharyngioma who have more incidence of metabolic syndrome (93). This evidence concerns the gene GH1 and hypopituitarism.